Company News
Emcure Subsidiary Acquires 100% of Mantra Pharma Shares
Emcure's subsidiary Marcan Pharmaceuticals acquired 100% of Class E Special Shares in step-down subsidiary Mantra Pharma for CAD $50 million.
The acquisition, executed on July 2, 2026, consolidates Ma
